Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
5.1 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Drug Control Act; adds certain chemicals to Schedules I, II, IV, and V of Act. | Drug Control Act; Schedule I; Schedule II; Schedule IV; Schedule V. Adds certain chemicals to Schedules I, II, IV, and V of the Drug Control Act. The Board of Pharmacy has added these substances in an expedited regulatory process. A substance added via this process is removed from the schedule after 18 months unless a general law is enacted adding the substance to the schedule. This bill incorporates HB 1450 and is identical to SB 111. | us/states/va | Virginia General Assembly | 2024 | HB 1333 | Virginia HB 1333 (2024) |
|
enacted |
|
4 | 29 | 5 | 2024-01-11 | 2024-03-08 | openstates | ocd-bill/1cee08bd-29af-4d33-a994-3d55e4de781a | https://lis.virginia.gov/cgi-bin/legp604.exe?241+sum+HB1333 | 94060ddeffa9623dc868f19c190841e6099b2b1419fe08e479ab368eb8cc7aa6 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Virginia HB 1333 (2024) — Drug Control Act; adds certain chemicals to Schedules I, II, IV, and V of Act.
Drug Control Act; Schedule I; Schedule II; Schedule IV; Schedule V. Adds certain chemicals to Schedules I, II, IV, and V of the Drug Control Act. The Board of Pharmacy has added these substances in an expedited regulatory process. A substance added via this process is removed from the schedule after 18 months unless a general law is enacted adding the substance to the schedule. This bill incorporates HB 1450 and is identical to SB 111.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- CHAP0062 (committee substitute) — source
- Committee substitute printed 24106671D-H1 (committee substitute) — source
- HB1333ER (committee substitute) — source
- Presented and ordered printed 24104366D (committee substitute) — source
Votes
- Reported from Health and Human Services with substitute (22-Y 0-N) — 22–0 (pass) · lower
- Passed Senate (39-Y 0-N) — 39–0 (pass) · upper
- Constitutional reading dispensed (38-Y 0-N) — 38–0 (pass) · upper
- Reported from Education and Health (13-Y 0-N) — 13–0 (pass) · upper
- VOTE: Block Vote Passage (98-Y 0-N) — 97–0 (pass) · lower
Sponsors
- H. Otto Wachsmann, Jr. — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2024-01-11 Presented and ordered printed 24104366D
introduction - 2024-01-11 Referred to Committee on Health and Human Services
referral-committee - 2024-01-12 Impact statement from VCSC (HB1333)
- 2024-01-24 Impact statement from DPB (HB1333)
- 2024-01-30 Reported from Health and Human Services with substitute (22-Y 0-N)
committee-passage - 2024-01-30 Committee substitute printed 24106671D-H1
substitution - 2024-01-30 Incorporates HB1450 (Thomas)
- 2024-01-31 Impact statement from DPB (HB1333H1)
- 2024-02-01 Read first time
reading-1 - 2024-02-02 Read second time
reading-2 - 2024-02-02 Committee substitute agreed to 24106671D-H1
substitution - 2024-02-02 Engrossed by House - committee substitute HB1333H1
substitution - 2024-02-05 Read third time and passed House BLOCK VOTE (98-Y 0-N)
passage, reading-3 - 2024-02-05 VOTE: Block Vote Passage (98-Y 0-N)
passage - 2024-02-06 Constitutional reading dispensed
- 2024-02-06 Referred to Committee on Education and Health
referral-committee - 2024-02-15 Reported from Education and Health (13-Y 0-N)
committee-passage - 2024-02-16 Constitutional reading dispensed (38-Y 0-N)
- 2024-02-19 Read third time
reading-3 - 2024-02-19 Passed Senate (39-Y 0-N)
passage - 2024-02-22 Enrolled
enrolled - 2024-02-22 Bill text as passed House and Senate (HB1333ER)
passage - 2024-02-22 Impact statement from DPB (HB1333ER)
- 2024-02-22 Signed by Speaker
passage - 2024-02-25 Signed by President
passage - 2024-03-01 Enrolled Bill communicated to Governor on March 1, 2024
enrolled, executive-receipt - 2024-03-01 Governor's Action Deadline 11:59 p.m., March 8, 2024
executive-receipt - 2024-03-08 Approved by Governor-Chapter 62 (effective 7/1/24)
executive-signature - 2024-03-08 Acts of Assembly Chapter text (CHAP0062)
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/1cee08bd-29af-4d33-a994-3d55e4de781a. Confidence: reported (aggregated from official Virginia legislature records).